Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This was a randomized, double-blind, parallel-group, multicenter study that used both an active control (fexofenadine) and a placebo control to evaluate desloratadine 5 mg once daily during a 15-day treatment period. The active treatments and placebo were allocated in a 2:2:1 ratio.
Epistemonikos ID: cee62e3fa50a8461b8b8076dc96e4ee92db86b5b
First added on: May 05, 2024